BY DR. NGOUNGOURE HALIMA, FIDELIE SCHOLASTIQUE
I welcomed my nomination for the WFN-JTF 2017 with pleasure and attended the 32nd International Epilepsy Congress Sept. 2-6, 2017, in Barcelona. (I would like to thank the WFN for giving me this opportunity.
Ngoungoure Halima
It was with great attention that I followed the several congress sessions. The ones that interested me most were the video sessions, in particular, those relating to seizures and epilepsy in neonates and the cases oriented series. Through the sessions on the new classification of epilepsy, epileptic encephalopathies concept treatment and outcome, and advanced EEG, I benefited from the advice of experts and updated my knowledge in epileptology.
Attending this conference also allowed me to present my poster whose research theme was betamethasone in the treatment of West syndrome. In fact, betamethasone is not a common oral steroid used in West syndrome. In our practice in Dakar, we use it because of its availability, low cost, and easy route of administration.
In addition to meeting with leading experts in the field of epilepsy, I also made new relationships for my future neurologist career.
At the end of this congress as a young neurologist, I am confident and ready to face the challenges of epilepsy in Africa.•
